+49 30 648 35 164 service@chameleon-pharma.com

The Philippines

Colorful and busy street in the Philippines

Featured image: Photo by Stel on Unsplash 

The Philippines: TRIUMPH Country

The Philip­pines could also be included among the top ten most attrac­tive Pharma mar­kets in the Asia-Pacific region. Within the ASEAN, the Philip­pines occupies the third posi­tion, just after Indone­sia and Thai­land. Unfortunately, their health­care sys­tem is so obso­lete that the mar­ket is unable to meet the health­care prod­uct quota that a big pop­u­la­tion demands.

There is nei­ther growth nor devel­op­ment present in the Filipino com­pa­nies that pro­duce OTC and Pharma prod­ucts. In com­par­i­son with China, where there is an obvi­ous desire to pro­duce domes­tic prod­ucts, the com­pa­nies in the Philip­pines are still depen­dent on for­eign man­u­fac­tur­ers. The level of devel­op­ment in the Pharma sec­tor is very mod­er­ate.

At present, mar­ket access in the Philip­pines—with the help of a sys­tem­at­i­cally selected part­ner—is still a rel­a­tively sim­ple and non-cost-intensive option. The next few years will see a great oppor­tu­nity to enter a top-ten market with branded prod­ucts in the Philippines. The OTC and Pharma mar­kets in neigh­bour­ing coun­tries, such as Thai­land and Malaysia, also show some poten­tial, albeit not on the level of the TRIUMPH markets.

CPC Press Releases on the Philippines: 

The Philippines: OTC and pharma market

The OTC and pharma market in 2030

USD 6,36 Billion

OTC and pharma market size


OTC and pharma market growth

The Philippines in numbers

Total population


Population growth

Birth rate

Mortality rate

Life expectancy

Interested in this market ?

We are ready to support you in Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory projects, and more in order to ensure your growth.